Monoclonal antibodies to GP110 of HIV and hybridomas secreting these antibodies
US5407811A · kind A · utility
5Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 1992 |
| Grant date | Apr 18, 1995 |
| Priority date | — |
| Expiry date | Sep 24, 2012 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/974
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
This invention is directed to an isolated antibody specific for gp110 glycoprotein of a human immunodeficiency virus type 1 (HIV-1), and a hybridoma which produces such an antibody. HIV-1 is the causative agent of Acquired Immunodeficiency Syndrome (AIDS).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.